Study guide

5.1 Acute Coronary Syndromes & Infarct Specific Complications

IBSC CCP-C Certified Critical Care Paramedic Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Strategy

1.1 About the CCP-C Exam 1.2 CCP-C Study Strategy & Exam Tactics

2 Chapter 2: Transport and Safety (Part 1)

2.1 Crew Resource Management & Sterile Cockpit Rule 2.2 Transport Risk Assessment & Mission Decision-Making 2.3 Aircraft and Ground Transport Safety Protocols

3 Chapter 2: Transport and Safety (Part 2)

2.4 Environmental Transport Stressors & Gas Laws 2.5 Transport Equipment Management & Post-Mission Operations

4 Chapter 3: Airway, Anesthesia, and Analgesics (Part 1)

3.1 Advanced Airway Assessment & Difficult Airway Identification 3.2 Rapid Sequence Induction (RSI) - Pretreatment & Induction Agents 3.3 Neuromuscular Blockade - Depolarizing vs Non-Depolarizing Agents 3.4 Post-Intubation Sedation, Analgesia & Dissociative Maintenance 3.5 Transport Ventilator Setup & Primary Ventilation Modes

5 Chapter 3: Airway, Anesthesia, and Analgesics (Part 2)

3.6 Mechanical Ventilator Waveforms, Loops & Oxygenation Titration 3.7 Ventilator Alarm Troubleshooting & Peak vs Plateau Pressures 3.8 Rescue Airway Devices, Video Laryngoscopy & Surgical Cricothyrotomy 3.9 Neuromuscular Reversal & Vasoactive Airway Support 3.10 Transport Airway Management in Unique Environments & Extubation

6 Chapter 4: General Medical Patient

4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation 4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm) 4.3 Renal and Hepatic Emergencies in Transport

7 Chapter 5: Cardiac Patient

5.1 Acute Coronary Syndromes & Infarct Specific Complications 5.2 Invasive Hemodynamic Monitoring 5.3 Vasoactive & Inotropic Medication Titration 5.4 Mechanical Circulatory Support & Post-Cardiac Arrest Care

8 Chapter 6: Neurological Patient

6.1 Traumatic Brain Injury & Intracranial Pressure (ICP) Management 6.2 Acute Ischemic Stroke, Hemorrhagic Stroke & Subarachnoid Hemorrhage 6.3 Status Epilepticus, Spinal Cord Injury & Neurogenic Shock

9 Chapter 7: Respiratory Patient

7.1 Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation 7.2 Severe Asthma & COPD Exacerbations in Critical Care 7.3 Chest Tube Management, Pleural Drains & Tension Pneumothorax 7.4 Pulmonary Embolism, Pulmonary Hypertension & Transport Respiratory Meds

10 Chapter 8: Toxic Exposure and Environmental Patient

8.1 Toxicology Emergencies, Toxidromes & Antidote Therapy 8.2 Environmental Emergencies (Hypothermia, Hyperthermia, Frostbite) 8.3 Submersion, Diving Emergencies & Envenomation/HazMat

11 Chapter 9: Trauma and Burn Patient

9.1 Hemorrhagic Shock Resuscitation & Massive Transfusion Protocols (MTP) 9.2 Severe Thoracic & Abdominal Trauma Management 9.3 Thermal, Chemical & Electrical Burn Assessment & Fluid Resuscitation 9.4 Musculoskeletal Trauma, Pelvic Fractures & Compartment Syndrome

12 Chapter 10: Maternal and Fetal Medicine

10.1 High-Risk Obstetric Assessment & Hypertensive Disorders of Pregnancy 10.2 Obstetric Hemorrhage, Placental Abruption & Preterm Labor 10.3 Emergency Transport Delivery, Umbilical Cord Prolapse & Fetal Monitoring

13 Chapter 11: Pediatric Patient

11.1 Pediatric Critical Care Airway & Transport Ventilation 11.2 Pediatric Shock, Dehydration & Weight-Based Dosing 11.3 Neonatal Resuscitation Program (NRP) & Transport of the Critical Neonate

14 Chapter 12: Special Populations

12.1 Bariatric Critical Care Transport & Positional Management 12.2 Geriatric Critical Care & Patients with Specialized Medical Technology

15 Chapter 13: Professional Considerations

13.1 Legal Aspects, EMTALA & Transport Ethics 13.2 Quality Improvement, Transport Safety Research & Evidence-Based Practice

5.1 Acute Coronary Syndromes & Infarct Specific Complications

Key Takeaways Explain This Topic AI

12-lead ECG localization maps ST elevation patterns to specific coronary arteries: LAD (Anterior/Septal V1-V4), RCA (Inferior II, III, aVF), and LCx (Lateral I, aVL, V5-V6), with reciprocal depressions in V1-V3 marking posterior wall infarction.

Right Ventricular Infarction (RVI) occurs in up to 40% of inferior MIs; diagnosis requires a right-sided ECG (V4R), and treatment demands aggressive preload preservation with IV fluid boluses while avoiding nitrates, morphine, and diuretics.

Cardiogenic shock is defined hemodynamically by a Cardiac Index < 2.2 L/min/m², elevated PAWP > 15 mmHg, and persistent hypotension (SBP < 90 mmHg) accompanied by tissue hypoperfusion.

Mechanical post-MI complications such as papillary muscle rupture, ventricular septal defect (VSD), and free wall rupture typically manifest 2 to 7 days post-MI and present with rapid hemodynamic collapse.

Pharmacological management of ACS requires dual antiplatelet therapy, unfractionated or low-molecular-weight heparin, and cautious antianginal titration based on hemodynamic stability.

Last updated: July 2026

5.1 Acute Coronary Syndromes & Infarct Specific Complications

Acute Coronary Syndrome (ACS) represents a continuum of myocardial ischemia and necrosis driven by acute disruption of epicardial coronary artery blood flow. The underlying pathophysiology typically involves atherosclerosis, plaque rupture or erosion, platelet activation, and subsequent thrombus formation. ACS is clinically categorized into three distinct entities: Unstable Angina (UA) , Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) , and ST-Segment Elevation Myocardial Infarction (STEMI) . In critical care transport, rapid identification of coronary anatomy, infarct localization, hemodynamic destabilization, and acute post-MI mechanical complications is essential for guiding resuscitation, pharmacological management, and transport destination decisions.

Pathophysiology & Coronary Vascular Anatomy

Myocardial perfusion is uniquely dependent on coronary blood flow during cardiac diastole, when ventricular contraction relaxes and epicardial vessel compression ceases. The two primary epicardial coronary arteries originate from the left and right sinuses of Valsalva above the aortic valve:

Left Main Coronary Artery (LMCA) : Bifurcates into the Left Anterior Descending (LAD) and Left Circumflex (LCx) arteries.

Left Anterior Descending (LAD) : Courses down the anterior interventricular sulcus. It supplies the anterior wall of the left ventricle, the anterior two-thirds of the interventricular septum, and the apex. Occlusion of the LAD causes anterior/septal infarctions, which carry high risks of cardiogenic shock, heart failure, and conductive disturbances (e.g., bundle branch blocks) due to extensive myocardial mass loss.

Left Circumflex (LCx) : Courses around the left AV groove. It supplies the lateral wall of the left ventricle and, in left-dominant circulation (10-15% of individuals), the posterior wall and posterior descending artery.

Right Coronary Artery (RCA) : Courses along the right AV groove, supplying the right atrium, right ventricle, and inferior wall of the left ventricle. In right-dominant vascular anatomy (85-90% of individuals), the RCA gives rise to the Posterior Descending Artery (PDA), which supplies the posterior wall and inferior one-third of the interventricular septum, as well as the AV nodal artery supplying the AV node.

12-Lead ECG Localization & Reciprocal Changes

Standard 12-lead electrocardiography provides non-invasive spatial localization of acute myocardial injury by detecting ST-segment shifts relative to the baseline TP segment. ST-segment elevation ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm ( 0.1 mV 0.1\text{ mV} 0.1 mV ) in two or more anatomically contiguous leads (or ≥ 1.5 − 2.0 mm \ge 1.5-2.0\text{ mm} ≥ 1.5 − 2.0 mm in leads V2-V3 depending on age and sex) defines a STEMI. Reciprocal ST-segment depression in anatomically opposing leads strongly confirms acute transmural infarction.

  • Anatomical Region Lead Distribution Primary Coronary Artery Reciprocal ECG Changes
  • Septal V1, V2 Left Anterior Descending (LAD - septal branches) None
  • Anterior V3, V4 Left Anterior Descending (LAD - diagonal branches) II, III, aVF (Inferior)
  • Anteroseptal V1 - V4 Left Anterior Descending (LAD) II, III, aVF
  • Inferior II, III, aVF Right Coronary Artery (RCA, ~85-90%) or LCx I, aVL (High Lateral)
  • Lateral (High) I, aVL Left Circumflex (LCx) or LAD diagonal II, III, aVF
  • Lateral (Low) V5, V6 Left Circumflex (LCx) or distal LAD V1, V2

Posterior V7, V8, V9 (or reciprocal V1-V3) RCA (PDA branch) or LCx V1, V2, V3 (ST depression, tall broad R waves, upright T waves)

Posterior Infarction Mechanics

Standard 12-lead ECGs do not directly view the posterior myocardium. Posterior wall infarction manifests in anterior leads (V1-V3) as mirror-image reciprocal changes: horizontal ST-segment depression, tall R waves ( R / S > 1.0 R/S > 1.0 R / S > 1.0 ), and broad upright T waves. Placing posterior leads V7 (left posterior axillary line), V8 (left mid-scapular line), and V9 (left paraspinal line) reveals ST elevation ≥ 0.5 mm \ge 0.5\text{ mm} ≥ 0.5 mm , confirming acute transmural posterior STEMI requiring immediate reperfusion.

Right Ventricular Infarction (RVI)

Right Ventricular Infarction occurs in up to 30-50% of inferior wall STEMIs due to proximal occlusion of the Right Coronary Artery (RCA) prior to the origin of the right ventricular marginal branches. Isolated RVI is rare. Proximal RCA Occlusion

  • │
  • ├─► Inferior LV MI (Leads II, III, aVF)
  • │
  • └─► RV Marginal Branch Ischemia
  • │
  • ▼
  • RV Dyskinesis & Dilation
  • │
  • ├─► Decreased RV Stroke Volume
  • │ │
  • │ ▼
  • │ Profound LV Underfilling (Preload Collapse)
  • │ │
  • │ ▼
  • │ Hypotension & Cardiogenic Shock
  • │
  • └─► Elevated Right Atrial Pressures (JVD + Clear Lungs)
  • Diagnostic & Hemodynamic Essentials of RVI

Right-Sided ECG : A right-sided 12-lead ECG (leads V1R-V6R) must be performed on all patients presenting with inferior STEMI. ST-segment elevation ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm in lead V4R (placed at the 5th intercostal space, right mid-clavicular line) is the single most sensitive and specific marker of acute right ventricular injury.

Triad of RVI : Hypotension, elevated Jugular Venous Pressure (JVD), and completely clear lung fields (absence of pulmonary rales/edema).

Preload Dependence : The infarcted right ventricle loses active contractile power and functions as a passive conduit. Maintenance of Right Ventricular (and subsequently Left Ventricular) output relies entirely on elevated central venous pressure (filling pressure).

Critical Contraindications : Administration of medications that reduce preload—such as Nitroglycerin , Morphine , Loop Diuretics (Furosemide) , or ACE inhibitors —causes immediate, catastrophic drops in cardiac output and severe hypotension.

Resuscitation Strategy : Treatment of RVI-induced hypotension requires aggressive volume expansion with continuous IV crystalloid boluses (e.g., 500-1000 mL normal saline or Lactated Ringer's) to raise CVP toward 14-18 mmHg. If hypotension persists despite volume loading, inotropic and vasopressor support with Norepinephrine (to maintain SBP/coronary perfusion) and Dobutamine (to enhance RV contractility) must be initiated.

Cardiogenic Shock in ACS

Cardiogenic shock represents severe end-organ tissue hypoperfusion resulting from primary cardiac pump failure, most commonly caused by loss of > 40 % > 40\% > 40% of functional left ventricular myocardium in acute transmural MI.

Clinical & Hemodynamic Diagnostic Criteria

Persistent Hypotension : Systolic Blood Pressure (SBP) < 90 mmHg < 90\text{ mmHg} < 90 mmHg or Mean Arterial Pressure (MAP) < 65 mmHg < 65\text{ mmHg} < 65 mmHg for > 30 minutes > 30\text{ minutes} > 30 minutes (or requiring vasopressor support).

Reduced Cardiac Index : CI < 2.2 L/min/m 2 \text{CI} < 2.2\text{ L/min/m}^2 CI < 2.2 L/min/m 2 (or < 2.0 L/min/m 2 < 2.0\text{ L/min/m}^2 < 2.0 L/min/m 2 with mechanical support).

Elevated Ventricular Filling Pressure : Pulmonary Artery Wedge Pressure (PAWP) > 15 mmHg > 15\text{ mmHg} > 15 mmHg or Right Atrial Pressure (CVP) > 10 − 12 mmHg > 10-12\text{ mmHg} > 10 − 12 mmHg .

End-Organ Hypoperfusion : Cool clammy extremities, oliguria ( < 0.5 mL/kg/hr < 0.5\text{ mL/kg/hr} < 0.5 mL/kg/hr ), altered sensorium, and arterial serum lactate > 2.0 mmol/L > 2.0\text{ mmol/L} > 2.0 mmol/L .

In cardiogenic shock, compensatory sympathetic reflex arc activation increases Systemic Vascular Resistance (SVR > 1200 dynes ⋅ sec/cm − 5 > 1200\text{ dynes}\cdot\text{sec/cm}^{-5} > 1200 dynes ⋅ sec/cm − 5 ) to preserve MAP. However, this marked afterload surge increases left ventricular wall stress and myocardial oxygen demand, creating a lethal spiraling decline in cardiac output.

Mechanical Post-MI Complications

Mechanical complications of acute myocardial infarction are life-threatening catastrophes that typically develop within 2 to 7 days post-MI during the tissue necrotic and macrophage-clearing phase. Critical care transport clinicians must immediately recognize their physical findings and hemodynamic signatures.

1. Papillary Muscle Rupture

Pathophysiology : Infarction of the papillary muscle causes acute loss of mitral valve leaflet tethering, resulting in catastrophic, massive acute mitral regurgitation .

Anatomical Vulnerability : The posteromedial papillary muscle is affected 6 to 10 times more frequently than the anterolateral papillary muscle. The posteromedial muscle has a single blood supply derived exclusively from the Posterior Descending Artery (RCA/LCx). In contrast, the anterolateral papillary muscle enjoys dual blood supply from both the LAD and LCx.

Clinical Presentation : Sudden onset of acute respiratory distress, flash pulmonary edema, severe cardiogenic shock, and a new harsh holosystolic murmur at the cardiac apex radiating to the axilla. Note: In hyperacute severe mitral regurgitation, atrial-ventricular pressure equalization can render the murmur faint or silent.

Management : Immediate afterload reduction with continuous Sodium Nitroprusside or Intra-Aortic Balloon Pump (IABP) counterpulsation to facilitate forward flow, alongside emergency surgical mitral valve repair/replacement.

2. Ventricular Septal Defect (VSD)

Pathophysiology : Transmural necrosis of the interventricular septum leads to wall rupture and the formation of an internal shunt.

Anatomical Distribution : Occurs in anterior MIs (apical septal rupture via LAD) or inferior MIs (basal septal rupture via RCA).

Clinical Presentation : Rapid biventricular failure, cardiogenic shock, and a new, harsh holosystolic murmur heard best at the left lower sternal border, frequently accompanied by a palpable parasternal thrill .

Hemodynamic Confirmation : Pulmonary Artery Catheter (PAC) sampling demonstrates an oxygen saturation step-up ( > 8 − 10 % > 8-10\% > 8 − 10% ) between the Right Atrium and Right Ventricle due to left-to-right shunting of oxygenated blood.

Management : Vasodilator/IABP afterload reduction and urgent surgical or transcatheter septal closure.

3. Ventricular Free Wall Rupture & Cardiac Tamponade

Pathophysiology : Complete transmural rupture of the left ventricular free wall into the pericardial sac, resulting in massive hemopericardium and acute cardiac tamponade.

Clinical Presentation : Sudden electromechanical dissociation (PEA arrest), profound hypotension, and classic Beck's Triad :

  • Hypotension with narrow pulse pressure
  • Distended neck veins (elevated CVP)
  • Muffled/distant heart sounds

Diagnostic Signs : Pulsus paradoxus ( > 10 mmHg > 10\text{ mmHg} > 10 mmHg drop in SBP during inspiratory phase) and electrical alternans on ECG.

Management : Immediate pericardiocentesis for temporary hemodynamic stabilization followed by emergency sternotomy and surgical repair.

Pharmacological Management of ACS

Acute medical therapy focuses on halting thrombus propagation, reducing myocardial oxygen demand, restoring coronary arterial flow, and stabilizing plaque.

Antiplatelet & Anticoagulant Regimens

Aspirin : Cyclooxygenase-1 (COX-1) inhibitor preventing thromboxane A2 production. Dose: 162 - 325 mg non-enteric coated tablet, chewed immediately.

P2Y12 Inhibitors : ADP receptor antagonists administered as dual antiplatelet therapy (DAPT).

Ticagrelor (Brilinta) : 180 mg loading dose, then 90 mg BID (reversible binding).

Prasugrel (Effient) : 60 mg loading dose, then 10 mg daily (contraindicated in prior stroke/TIA).

Clopidogrel (Plavix) : 300 - 600 mg loading dose, then 75 mg daily.

Anticoagulation :

Unfractionated Heparin (UFH) : IV bolus 60 units/kg (maximum 4000 units), followed by infusion at 12 units/kg/hr (maximum 1000 units/hr), titrated to maintain anti-Xa or aPTT 1.5 - 2.0 times control (typically 50-70 seconds).

Enoxaparin (Lovenox) : 1 mg/kg SC q12h (or 0.75 mg/kg for severe renal impairment).

Antianginal & Hemodynamic Titration

Nitroglycerin : Direct venous and arterial vasodilator. Administered sublingually (0.4 mg q5min x 3) or IV infusion (5 - 200 mcg/min). Reduces LV preload and PAWP. Absolute contraindications : Right Ventricular Infarction, SBP < 90 mmHg < 90\text{ mmHg} < 90 mmHg , bradycardia < 50 bpm < 50\text{ bpm} < 50 bpm , or recent phosphodiesterase-5 inhibitor use (sildenafil within 24h, tadalafil within 48h).

Beta-Blockers : Oral Metoprolol (25-50 mg q6h) initiated within 24 hours reduces ventricular dysrhythmias and infarct size by decreasing HR and contractility. Absolute contraindications : Acute heart failure, cardiogenic shock, severe bradycardia, or second/third-degree AV block.